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The single largest source of chemical exposure
on military bases of the North Atlantic Treaty
Organization (NATO) is jet propulsion
fuel 8 (JP-8), which is the preferred fuel for
both aircraft and military vehicles in NATO
countries. JP-8 comprises many aromatic
hydrocarbons, including benzene and naph-
thalene, and aliphatic hydrocarbons such as
nonane and decane (McDougal et al. 2000).
Exposures to JP-8 can occur during spills,
transportation and storage of the fuel, as well
as during fueling, general maintenance and
operation of aircraft and military vehicles,
fueling of military tent heaters, and cleaning
and degreasing of parts with the fuel. 
Since JP-8 can enter the body via both
inhalation and dermal contact, the assessment
of occupational exposures to fuel constituents
can be difficult. Personal sampling of JP-8
vapors provides information about inhalable
levels but not about dermal exposure levels.
Similarly, sampling the exposed skin provides
information about dermal but not about
inhalable levels. Conversely, the collection of
end-exhaled breath concentrations provides
an integrated estimate of uptake via both
inhalation and dermal contact (Egeghy et al.
2003; Pleil et al. 2000) but cannot determine
the relative contributions of the two exposure
routes to the internal dose. Through statistical
evaluation of levels of naphthalene in air,
breath, and skin, measured in the U.S. Air
Force personnel during fuel maintenance pro-
cedures, both inhalation and dermal exposures
to JP-8 were demonstrated to contribute to the
internal dose (Chao et al. 2006). However,
because of the respiratory protection used in
that population, it was difﬁcult to determine
the relative contributions of dermal and
inhalation exposures to the systemic levels of
JP-8 components.
Physiologically based toxicokinetic
(PBTK) modeling is an effective tool for
quantifying the absorption, distribution,
metabolism, and elimination of chemicals.
PBTK models have been developed for vari-
ous components of JP-8, notably naphthalene
and decane (Perleberg et al. 2004; Quick and
Shuler 1999; Willems et al. 2001). The
model developed by Quick and Shuler
(1999) focused on the disposition of naph-
thalene in ﬁve compartments representing the
lungs, liver, fat, rapidly perfused tissues, and
slowly perfused tissues and relied on in vitro
data to calibrate kinetic constants. Willems
et al. (2001) refined the Quick and Shuler
(1999) model by using kinetic constants
derived from in vivo data from laboratory
animal experiments performed by the
National Toxicology Program. They observed
that a diffusion-limited PBTK model was nec-
essary to characterize the toxicokinetic behav-
ior of naphthalene in rats and mice. Perleberg
et al. (2004) developed a PBTK model using
decane as a chemical marker of JP-8. Data for
calibration and validation of this model were
derived from an animal study in which rats
were exposed for 4 hr to decane vapor at three
different concentrations (1,200, 781, or 273
ppm). Their final model consisted of flow-
limited compartments for liver and lung, and
diffusion-limited compartments for brain,
bone marrow, fat, skin, and spleen. The
model predicted the time course of decane in
tissue and blood from low-level exposures to
decane vapor.
Because the PBTK models mentioned
above did not examine the uptake via skin, we
developed a PBTK model that included both
inhalation and dermal routes of exposure.
Naphthalene was chosen as the surrogate for
JP-8 exposure because it is abundant in JP-8,
is readily absorbed into blood, and is only a
minor component in confounding sources of
exposure such as cigarette smoke and gasoline
exhaust (Rustemeier et al. 2002; Serdar et al.
2003). We expanded on the structure of a
data-based compartmental model that was
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BACKGROUND: Dermal and inhalation exposure to jet propulsion fuel 8 (JP-8) have been measured
in a few occupational exposure studies. However, a quantitative understanding of the relationship
between external exposures and end-exhaled air concentrations has not been described for occupa-
tional and environmental exposure scenarios.
OBJECTIVE: Our goal was to construct a physiologically based toxicokinetic (PBTK) model that
quantitatively describes the relative contribution of dermal and inhalation exposures to the end-
exhaled air concentrations of naphthalene among U.S. Air Force personnel.
METHODS: The PBTK model comprised five compartments representing the stratum corneum,
viable epidermis, blood, fat, and other tissues. The parameters were optimized using exclusively
human exposure and biological monitoring data.
RESULTS: The optimized values of parameters for naphthalene were a) permeability coefﬁcient for
the stratum corneum 6.8 × 10–5 cm/hr, b) permeability coefﬁcient for the viable epidermis 3.0 ×
10–3 cm/hr, c) fat:blood partition coefﬁcient 25.6, and d) other tissue:blood partition coefﬁcient
5.2. The skin permeability coefﬁcient was comparable to the values estimated from in vitro studies.
Based on simulations of workers’ exposures to JP-8 during aircraft fuel-cell maintenance opera-
tions, the median relative contribution of dermal exposure to the end-exhaled breath concentration
of naphthalene was 4% (10th percentile 1% and 90th percentile 11%).
CONCLUSIONS: PBTK modeling allowed contributions of the end-exhaled air concentration of
naphthalene to be partitioned between dermal and inhalation routes of exposure. Further study of
inter- and intraindividual variations in exposure assessment is required to better characterize the
toxicokinetic behavior of JP-8 components after occupational and/or environmental exposures.
KEY WORDS: dermal, exposure assessment, inhalation, jet fuel, naphthalene, physiologically based
toxicokinetic model. Environ Health Perspect 115:894–901 (2007). doi:10.1289/ehp.9778 avail-
able via http://dx.doi.org/ [Online 14 February 2007]used to quantify the absorption, distribution,
and elimination of jet fuel components (Kim
et al. 2006b). Data from a study of controlled
dermal exposure in humans were used to opti-
mize the parameters in the PBTK model (Kim
et al. 2006a). The optimal PBTK model,
combined with exposure and biomarker data
from ﬁeld studies (Chao et al. 2005; Egeghy
et al. 2003), was used to quantify the relative
contributions of dermal and inhalation expo-
sures to end-exhaled breath concentrations of
naphthalene among U.S. Air Force personnel.
Materials and Methods
Laboratory study of dermal exposure to JP-8.
We conducted a laboratory study to quantify
the dermal absorption and penetration of JP-8
components across human skin in vivo (Kim
et al. 2006a). Approval for this study was
obtained from the Ofﬁce of Human Research
Ethics (School of Public Health, The
University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina). Written
informed consents were received from all
study volunteers. The study consisted of
10 volunteers (5 females and 5 males) recruited
for this study. Exposures were conducted in an
exposure chamber. One forearm was placed
palm up inside the exposure chamber, and two
aluminum application wells were pressed
against the skin and sealed for the duration of
the experiment (0.5 hr). At the end of the
0.5-hr exposure period, the exposed sites were
tape-stripped 10 times with adhesive tape
strips. Tape strips were used to quantify the
mass of naphthalene in successive layers of the
stratum corneum. Both tape-strip and blood
samples were analyzed by gas chromatogra-
phy–mass spectrometry (GC-MS). The time
course of naphthalene in blood for all study
volunteers showed considerable interindivid-
ual variability. For example, the time course
for a 23-year-old Caucasian male with a body
mass index (BMI) of 25 kg/m2 was very dif-
ferent from that of a 24-year-old Caucasian
female with a BMI of 22 kg/m2. For the male
volunteer, the maximum concentrations in
blood (Cmax) occurred shortly after the end of
exposure (tmax ≈ 30 min), with a value of
0.8 ng/mL. The Cmax for the female volunteer
occurred at tmax ≈ 60 min, with a value of
0.3 ng/mL. In either case, the concentrations
in blood at t > 0 min did not return to base-
line levels. 
Field study of dermal and inhalation
exposures to JP-8. Exposure data were obtained
from the assessment of dermal and inhalation
exposures to JP-8 in the personnel at six U.S.
Air Force bases in the continental United
States (Chao et al. 2005; Egeghy et al. 2003).
The duration of exposure was approximately
4 hr. The concentration of naphthalene in the
personal breathing-zone air (referred to as “air
concentration” in this article) was measured
using passive monitors (Egeghy et al. 2003).
End-exhaled breath samples were collected pre-
and postexposure (Egeghy et al. 2003). The
end-exhaled breath measurements are indica-
tive of alveolar air (Egeghy et al. 2000). Both
air and breath samples were analyzed by GC
with photoionization detection. Tape strips
were used to quantify dermal exposure to
naphthalene at specific body regions; results
were extrapolated to the total surface area of
skin to estimate whole-body dermal exposure
to naphthalene. We collected dermal samples
postexposure using adhesive tape strips with
the dimension of 2.5 cm × 4.0 cm (surface area
10 cm2) from exposed body regions including
the forehead, neck, shoulders, arms, hands,
legs, knees, feet, and buttocks (Chao et al.
2005). Tape-strip samples were extracted with
acetone and analyzed by GC-MS.
The median air concentrations of naph-
thalene in air samples were 1.9 μg/m3 (range,
< 1.0–16.9 μg/m3), 29.8 μg/m3 (range,
< 1.0–932 μg/m3), and 867 μg/m3 (range,
12.8–3,910 μg/m3) for the low-, medium-,
and high-exposure groups, respectively
(Egeghy et al. 2003). The median preexposure
breath levels of naphthalene were < 0.5 μg/m3
(range, < 0.5–36.3 μg/m3), < 0.5 μg/m3
(range, < 0.5–16.1 μg/m3), and < 0.5 μg/m3
(range, < 0.5–6.1 μg/m3) for the low-,
medium-, and high-exposure groups, respec-
tively. The median postexposure breath levels
were 0.73 μg/m3 (range, < 0.5–6.9 μg/m3),
0.93 μg/m3 (range, < 0.5–13.0 μg/m3), and
1.83 μg/m3 (range, < 0.5–15.8 μg/m3) for the
low-, medium-, and high-exposure groups,
respectively. The corresponding median con-
centrations of dermal samples were 344 ng/m2
(range, 159–54,200 ng/m2), 483 ng/m2
(range, 150–13,200 ng/m2), and 4188 ng/m2
(range, 100–4,880,000 ng/m2) in the low-,
medium-, and high-exposure groups, respec-
tively (Chao et al. 2005).
Description of the PBTK model. A
dermatotoxicokinetic (DTK) model, which
was previously developed for describing the
disposition of aromatic and aliphatic compo-
nents of JP-8 after controlled dermal exposure
(Kim et al. 2006b), formed the basis of the
PBTK model (Figure 1). The DTK model
consisted of five compartments representing
the surface, stratum corneum, viable epider-
mis, blood, and storage tissues. The parame-
ters for the DTK model were estimated by
ﬁtting the model to the data. The major dif-
ference between the DTK and the PBTK
model structures is that the storage compart-
ment was split into fat and all other tissues.
The rationale for defining the storage com-
partment in this fashion was based on the high
fat:blood partition coefﬁcient (Pf:b) of naph-
thalene (160), which is more than 5 times the
partition coefficient of the other tissues
(Fiserova-Bergerova 1983). Further additions
to the PBTK model included pulmonary
uptake and clearance. The skin compartments
were composed of the skin directly under the
exposed area. All tissues were perfusion limited
and well mixed. Absorbed naphthalene was
distributed to other tissue compartments at a
rate equal to the rate of blood ﬂow to that tis-
sue. Naphthalene was stored in the fat and
other tissue compartments based on the physi-
ologic parameters of that compartment (i.e.,
tissue:blood partition coefficient, tissue vol-
ume, and blood perfusion rate). 
Most physiologically based compartmental
models separate the arterial blood from the
central venous blood, whereas data-based
compartmental models treat the blood as one
compartment. Also in data-based compart-
mental models, the peripheral compartments
represent organs or tissues that, being poorly
perfused with blood, are in slower equilibrium
distribution with blood. Blood samples were
collected from the antecubital vein in the study
by Kim et al. (2006a). The antecubital vein
drains blood from the hand and the superﬁcial
layers of the forearm. The concentration of
PBTK model of human exposure to naphthalene
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Figure 1. Schematic of the physiologically based
toxicokinetic (PBTK) models for the study of naph-
thalene toxicokinetics. Pulmonary uptake of naph-
thalene in the personal breathing-zone and
pulmonary clearance from the blood compartment
are added to a previously published dermatotoxi-
cokinetic model (Kim et al. 2006b). Abbreviations in
the PBTK model: Kuptake, input rate constant for
dermal exposure; Kpv, permeability coefficient for
the viable epidermis; Aexp, exposed surface area;
Psc:ve, stratum corneum:viable epidermis partition
coefﬁcient; QE, blood ﬂow rate to skin; Pve:b, viable
epidermis:blood partition coefficient; QP, pul-
monary ventilation rate; Pb:a, blood:air partition
coefﬁcient; QF, blood ﬂow rate to fat; Pf:b, fat:blood
partition coefficient; QO, blood flow rate to other
tissue; Po:b, other tissue:blood partition coefﬁcient;
EL, extraction ratio.
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Other
Kuptake
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QF/Pf:b
QO/Po:bsolute in the antecubital vein is different
from the concentrations of solute in the arte-
rial and central venous blood (Levitt 2004).
However, the blood in the antecubital vein is
in rapid equilibrium with arterial and central
venous blood relative to the fat and other tis-
sue compartments. Therefore, we treated the
arterial and central vein as a single compart-
ment, and approximated the concentration
of naphthalene in the central (i.e., blood)
compartment using measurements made
from the antecubital vein.
Two routes of exposure were modeled:
dermal and inhalation. Pulmonary uptake is
equal to the pulmonary ventilation rate (QP)
times the concentration of naphthalene in the
personal breathing-zone (CPBZ):
Pulmonary uptake = QP × CPBZ. [1]
In Equation 1, rapid equilibration of naph-
thalene occurs across the alveolar lining, and
neither storage nor metabolism in the lungs
appreciably affects the uptake of naphthalene
into the systemic circulation. Because arterial,
lung, and venous blood are treated as a com-
bined blood compartment, the rate of absorp-
tion is equal to pulmonary uptake. Dermal
absorption and penetration is modeled as a
one-directional diffusive process according to
Fick’s ﬁrst law of diffusion. As such, the diffu-
sion of naphthalene across the stratum
corneum (SC) and the viable epidermis (VE)
are quantiﬁed using permeability coefﬁcients,
the area of exposure, and the thickness of the
membrane (McCarley and Bunge 2001;
McDougal and Boeniger 2002). The rate of
efﬂux from the SC to the VE is dependent on
the solubility of naphthalene in the SC rela-
tive to the VE. Therefore, the rate of efﬂux of
naphthalene from the SC to the VE is equal
to Kpv × Aexp × CD/Psc:ve, where Kpv is the
permeability coefﬁcient across the VE, CD is
the concentration in the SC, Aexp is the
exposed surface area, and Psc:ve is the SC:VE
partition coefﬁcient. The mass balance differ-
ential equation (MBDE) for the SC is
[2]
where Kuptake is the input rate constant and
DERMDOSE is the dose to the skin. The rate
of input from blood to VE is the cutaneous
blood ﬂow rate (QE) times the concentration
of naphthalene in blood (CB), and the rate of
efﬂux from the VE to blood is controlled by
QE and the solubility of naphthalene in the
blood (Pve:b). The MBDE for the amount of
naphthalene in the VE is
[3]
where AE is the amount and CE is the
concentration of naphthalene in the VE.
Elimination of naphthalene proceeds by
two significant mechanisms: exhalation and
metabolism. The concentration of naphthalene
in end-exhaled air is equal to the blood con-
centration divided by the blood:air partition
coefficient (Pb:a). Pulmonary clearance of
naphthalene is QP divided by Pb:a. Metabolism
of naphthalene occurs in the liver by a single
metabolic pathway following ﬁrst-order kinet-
ics. The initial step in naphthalene metabolism
is the formation of naphthalene-1,2-oxide by
cytochrome P450 monooxygenases [Agency
for Toxic Substances and Disease Registry
(ATSDR) 1995]. Liver clearance (ClL) is
, [4]
where Vmax (millligrams per minute) is the
maximum rate of metabolism, Km (milligrams
per liter) is the Michaelis-Menten constant,
and QL the blood ﬂow rate to the liver (liters
per minute). The ratio of liver clearance to
liver blood flow is the extraction ratio (E L)
where EL is
. [5]
Determination of the blood:air partition
coefﬁcient. Initial sensitivity analysis revealed
that the concentration of naphthalene in end-
exhaled air was highly sensitive to Pb:a.
Therefore, we measured Pb:a by equilibrating
human blood with a known concentration of
naphthalene (Gargas et al. 1989). Samples
were analyzed with a Combi Pal autosampler
configured for headspace analysis (CTC
Analytics, Zwingen, Switzerland). A series of
20-mL crimp seal vials (MicroLiter Analysis
Supplies, Suwanee, GA, USA) containing
blood (test), air (reference), and a known
amount of naphthalene (gas) were used in the
experiment. The test and reference vials
underwent the same process. First, the vial was
heated to a temperature of 37°C, and a vent
tool (LEAP Technologies, Carrboro, NC,
USA) was used to equilibrate the pressure
between the test/reference vials and the room.
Next, a 2.5-mL gas-tight syringe was used to
draw from the vial 1 mL of air, which was
injected into the room air. Then, 1 mL of gas
from the gas vial was transferred to the
test/reference vial. The test/reference vial was
kept at 37°C and agitated for 1 hr; we deter-
mined, by adjusting the incubation period,
that 1 hr was the optimal time for achieving
equilibrium. After incubation, a 1-mL sample
was extracted from the test/reference vial and
injected into the GC-MS for analysis. All
analyses were conducted in triplicate. A six-
point standard curve (R 2 = 0.999) was used
for quantitation of the naphthalene concentra-
tion in the test and reference vials. Partition
coefﬁcients were determined using Equation 6
(Gargas et al. 1989).
, [6]
where Cref is the naphthalene concentration
in the reference vial, Vvial is the volume of the
reference vial (20 mL), Cblood is the naphtha-
lene concentration in the headspace of the test
vial, and Vblood is the volume of blood
(2 mL). Using Equation 6, we calculated a
Pb:a value of 10.3.
Model optimization. All physiologic para-
meters (cardiac output, ventilation rate, blood
ﬂow rate to the tissues, and tissue volumes) for
humans were obtained from the literature
(Brown et al. 1997). Other tissue partition
coefﬁcients were predicted from the octanol–
water partition coefficients and regression
models for different tissues (Abraham et al.
1985; Fiserova-Bergerova et al. 1984; Hansch
et al. 1995; Willems et al. 2001). The maxi-
mum rates of naphthalene metabolism (Vmax)
and Michaelis-Menten constant (Km) have
been estimated for rats and mice (Willems
et al. 2001). In our study, the rate of metabo-
lism was assumed to follow ﬁrst-order kinetics,
given the relatively low naphthalene concentra-
tions measured in post-exposure breath sam-
ples (Egeghy et al. 2003). Initial sensitivity
analysis revealed that the concentration of
naphthalene in end-exhaled breath was not
sensitive to Vmax/Km. Therefore, the parame-
ters Kuptake, Kpv, Pf:b, and Po:b (other
tissue:blood partition coefficient) were
adjusted to ﬁt the blood time course data for
each volunteer in the laboratory study. Initial
values of all parameters were obtained from
the literature (Guy and Potts 1992; McCarley
and Bunge 2001; Qiao et al. 2000; Willems
et al. 2001; Williams and Riviere 1995). The
Nelder-Mead algorithm, with tolerance set at
1 × 10–5, was used to optimize the parameters
(Xcellon 2004).
Comparison of dermal and inhalation
routes of exposure. The Air Force data set was
used to compare the relative contribution of
dermal exposure with the end-exhaled breath
concentration of naphthalene. The data set
included personnel from the U.S. Air Force
who had both dermal and inhalation expo-
sures to JP-8 (Chao et al. 2005; Egeghy et al.
2003). From the Air Force personnel, end-
exhaled breath samples were collected imme-
diately at the end of the work shift and, later,
at a central testing site (CTS). Three Air
Force personnel were selected who repre-
sented the 10th, 50th, and 90th percentiles
based on their end-exhaled breath measure-
ments. The group had regular contact with jet
fuel, and consisted of fuel-cell maintenance
P
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work. Thus, the concentration of naphthalene
in the air was much higher in the immediate
work environment for these individuals com-
pared with personnel who had no direct con-
tact with JP-8 and, therefore, represented
background exposures to naphthalene. The
air concentration of naphthalene was reported
for the duration of the sampling period,
which included travel time to the CTS
(~ 30 min). Thus, the air concentration at the
work site was estimated as
[7]
where INHAL1est is the estimated concentra-
tion of naphthalene in the breathing zone
during the work shift of Δtwork hr, CPBZ is the
air concentration measured during the full
sampling period of Δttotal hr, INHAL2est is the
estimated background air concentration of
naphthalene (i.e., air measurements from the
U.S. Air Force personnel who had no direct
contact with JP-8), and Δttravel is the time
required to travel from the workplace to the
CTS. The concentrations of naphthalene in
the air and dermal samples and the duration
of exposure were used as input terms for the
PBTK model. Predicted end-exhaled breath
concentrations were compared with measured
levels of naphthalene in end-exhaled breath.
Sensitivity analysis. Sensitivity analyses
were performed to evaluate the relative
importance of model parameters on the con-
centration of naphthalene in end-exhaled
breath. Normalized sensitivity coefficients
(NSC) were calculated using Equation 8
(Evans and Andersen 2000): 
, [8]
where m is the response variable (i.e., concen-
tration of naphthalene in end-exhaled breath),
Δm is the change in the response variable, p is
the value of the parameter of interest (e.g.,
blood:air partition coefﬁcient), and Δp is the
change in the parameter value. Each parame-
ter was changed 1% (i.e., Δp ÷ p = 0.01).
Results
Dermal exposure toxicokinetics. The PBTK
model was optimized for dermal exposure
using data from 10 individuals who were
exposed to JP-8 on the skin under laboratory
conditions. The average height and weight of
the subjects to whom JP-8 was administered
on the skin was 174 cm and 61 kg, respec-
tively (BMI = 21 kg/m2). Time-course plots
showed considerable variability among the
study volunteers (Figure 2). The mean ± SD
of the peak concentration of naphthalene in
blood was 0.18 ± 0.22 ng/mL and occurred at
62 ± 16 min. The time course for subject
no. 1 was very different from that of the other
volunteers. The peak concentration for this
volunteer was 0.80 ng/mL and occurred at
37 min. Model predictions of the blood con-
centration of naphthalene are also shown for
each volunteer using optimized parameter val-
ues in Figure 2. The skin parameters (Kuptake
and Kpv) and the partition coefficients Pf:b
and Po:b were adjusted to ﬁt the blood time-
course data for dermal exposures only; the
optimal values are reported in Table 1. The
rate of input from dermal exposure is equiva-
lent to the product of the permeability coefﬁ-
cient for the SC (Kps), the exposed surface
area (Aexp), and the concentration of the
naphthalene in JP-8 (CJP-8) (McCarley and
Bunge 2001; McDougal and Boeniger 2002): 
NCS =× Δ
Δ
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PBTK model of human exposure to naphthalene
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Figure 2. Plots comparing the PBTK model simulations to experimentally measured naphthalene concen-
trations in blood from 10 study volunteers (A–J) who were dermally exposed to JP-8 on the volar forearm.
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Equation 9 can be rearranged to solve for Kps
as follows:
. [10]
The optimized value of Kuptake is 0.031 ±
0.056 hr–1 (mean ± SD), and for Kps it is 6.8 ×
10–5 ± 5.8 × 10–5 cm/hr (mean ± SD)
(Table 2). The sensitive parameters in the der-
mal only model were DERMDOSE (NSC =
1.0), Aexp (NSC = 1.0), Kuptake (NSC = 1.0),
and Po:b (NSC = –0.3).
Prediction of end-exhaled breath concen-
trations. The optimized PBTK model was used
to predict the end-exhaled breath concentra-
tion of naphthalene for 53 U.S. Air Force per-
sonnel (13 females and 40 males) who did not
have dermal contact with jet fuel and had
naphthalene end-exhaled breath concentrations
> 0.0 μg/m3. The median height and weight of
the personnel were 175 cm (range,
155–193 cm) and 77 kg (range, 52–116 kg),
respectively. In the simulation, the median air
concentration of naphthalene was 2.4 μg/m3
(range, 0.7–481.7 μg/m3) and was held con-
stant for the duration of exposure (median
duration, 237 min). For each U.S. Air Force
subject, the preexposure concentration of
naphthalene in the end-exhaled breath was
subtracted from the postexposure measure-
ments. The predicted concentration of naph-
thalene in end-exhaled breath (0.5 μg/m3) was
the same as the median of the measured values.
In addition, comparisons were made between
measured and predicted concentrations of
naphthalene in end-exhaled breath for each
U.S. Air Force subject, using information on
the subject’s height, weight, air concentration
of naphthalene, and duration of exposure. The
median relative difference between measured
and predicted values was 26% (10th–90th per-
centile range, –71 to 196%).
Model predictions of the end-exhaled
breath concentration of naphthalene were
compared with field measurements among
three Air Force personnel who represented the
10th, 50th, and 90th percentiles based on their
end-exhaled breath measurements. These three
U.S. Air Force personnel spent time in a fuel
tank during their work shift and were exposed
to JP-8 on the skin. The input parameters and
values for each U.S. Air Force personnel are
reported in Table 3. The PBTK model consis-
tently overpredicted the end-exhaled breath
concentrations at the end of work shift for all
three U.S. Air Force personnel (Figure 3). This
could be attributed to the use of supply-air res-
pirators. Therefore, the air concentration of
naphthalene during work (i.e., INHAL1est) was
adjusted (i.e., INHAL1adj) to estimate the
likely inhalation exposure (Figure 3). The
values of INHAL1adj are reported in Table 4.
Comparison of dermal and inhalation expo-
sure routes. Simulations were conducted for
three U.S. Air Force personnel to compare the
contribution of dermal exposure with the end-
exhaled breath concentrations relative to inhala-
tion exposure (Table 4). These three individuals
were fuel-cell maintenance workers. The area
under the end-exhaled breath concentration
time curve (AUCex) was calculated for dermal
exposures using the following equation:
, [11]
where Cex is the concentration of naphthalene
in the end-exhaled breath and t1 is the time at
the end of the exposure. The values of AUCex
for dermal exposures were 1.7, 41.7, and
521 μg × min/m3 for the 10th, 50th, and 90th
percentiles, respectively. Dermal exposures
were set to zero and the naphthalene air con-
centration was adjusted to obtain the same
value of AUCex. The predicted air concentra-
tions (INHAL1pred) were 0.1, 0.7, and 11.7
μg/m3, respectively. These values are 1, 4, and
11% of the air concentrations of naphthalene
for the individuals whose breath meas-
urements represented the 10th, 50th, and
90th percentiles, respectively.
AUC C t t
t
t
ex ex d = ∫ ()
0
1
K
KD E R M D O S E
AC
ps
uptake
JP-8
=
×
× exp
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Table 1. Naphthalene PBTK model parameters.
Parameter Symbol Unit Value Notes and references
Body weight BW kg 61 Kim et al. (2006a)
Height HT cm 174 Kim et al. (2006a)
Body mass index BMI kg/m2 20 BMI = BW/HT2
Organ volumes
Blooda Vb L 4.5 BW = (72.447/1000) × BW1.007
Stratum corneum Vsc L2   × 10–5 VD = Aexp × Td
Viable epidermisb Vve L 1.9 × 10–3 VE = VEC × BW–VD
Fatc Vf L 5.5 VF = BW × (ln BMI–126.2)/100
Other tissue Vo L 51.0 VO = BW–(VB + VD + VE + VF)
Pulmonary ventilation rate QP L/hr/BW0.75 15 Brown et al. (1997)
Cardiac output QC L/hr/BW0.75 15 Brown et al. (1997)
Regional blood ﬂow
To skind QE L/hr 1.7 × 10–2 QE = QEC × (Aexp/SURFA)
To fat QF L/hr 16.4 QF = QFC × QC
To other tissues QO L/hr 311.0 QO = QC–(QE + QF)
Metabolic clearance parameters
Ratio of Vmax:Km Vmax/Km L/hr 698 Willems et al. (2001)
Blood ﬂow to liver QL L/hr 75.3 QL = QLC × QC
Partition coefﬁcients
Blood:air Pb:a — 10.3 Measurede
Stratum corneum:viable epidermis Psc:ve — 1.8 McCarley and Bunge (2001)
VE:blood Pve:b — 2.8 McCarley and Bunge (2001)
Fat:blood Pf:b — 25.6 Estimatedf
Other tissue:blood Po:b — 5.2 Estimatedf
Skin permeation parameters
Area of exposure Aexp cm2 20 Dimensions of the tape strip
Thickness of the stratum corneum Td µm 10 McCarley and Bunge (2001)
Total body surface areag SURFA cm2 19,238 (BW 0.45) × (HT 0.725) × 71.84
Permeability coefﬁcient for stratum corneum Kps cm/hr 6.8 × 10–5 Estimatedf
Permeability coefﬁcient for viable epidermis Kpv cm/hr 3.0 × 10–3 Estimatedf
aFrom Davies and Morris 1993. bThe volume of the viable epidermis is calculated as the volume of the exposed skin minus
the volume of the stratum corneum under the exposed area. The fraction of body weight in skin (VEC) is from Brown et al.
(1997). cThe fraction of body weight in fat = ln BMI–126.2 (Mills 2005). dThe fractions of cardiac output to skin (QEC) and to
liver (QLC) were obtained from Brown et al. (1997). eThe blood:air partition coefﬁcient was measured using the vial equili-
bration technique (Gargas et al. 1989). fModel parameters were estimated by ﬁtting the model to the data (Figure 2). gTotal
body surface area (Haycock et al. 1978).
Table 2. Optimized values of the skin parameters Kuptake, Kpv, Pf:b, and Po:b. Kps were calculated using
Equation 10. The parameters were optimized for each of the 10 study volunteers.
Volunteer Kuptake × 10–3 (hr–1) Kps × 10–5 (cm/hr) Kpv × 10–3 (cm/hr) Pf:b Po:b
1 190.7 18.8 7.6 4.4 0.6
2 4.4 1.1 1.5 0.1 0.6
3 13.6 8.0 0.6 1.6 8.9
4 21.3 3.2 3.1 15.2 2.4
5 16.9 11.8 2.4 15.4 12.2
6 22.8 11.7 1.7 3.1 8.3
7 12.2 6.8 2.1 22.4 2.7
8 18.6 4.1 5.4 11.1 16.1
9 8.3 1.5 2.2 7.3 0.3
10 3.7 1.3 3.5 175.7 0.1
Mean ± SD 31.3 ± 56.4 6.8 ± 5.8 3.0 ± 2.1 25.6 ± 53.2 5.2 ± 5.8PBTK model of human exposure to naphthalene
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Sensitivity analysis. Normalized sensitiv-
ity coefficients (mean) were calculated sepa-
rately for exposure and physiologic
parameters. The sensitivity analysis was con-
ducted for a typical mixed exposure scenario,
that is, the subject representing the 50th per-
centile in terms of end-exhaled breath meas-
urements. Each parameter was changed 1%
from its optimal value (Table 1) in the for-
ward direction (Equation 8). The response
variable in both sets of calculations was the
concentration of naphthalene in the end-
exhaled breath. For exposure variables, the
end-exhaled breath concentration was most
sensitive to the estimated air concentration of
naphthalene during work (NSC = 1.0). End-
exhaled breath concentrations were not sensi-
tive to the variables DERMDOSE and Aexp, as
the dermal route accounts for only a small
percentage of total exposure in these individu-
als. In the multidose route PBTK model, the
end-exhaled breath concentration of naphtha-
lene was most sensitive to cardiac output
(NSC = –0.7), ventilation rate (NSC = 0.9),
and the blood:air partition coefﬁcient (NSC =
–0.9) (Figure 4). The NSCs for other parame-
ters were < |0.2|.
Discussion
A PBTK model was developed to predict end-
exhaled breath concentrations of naphthalene
from dermal and inhalation exposure to JP-8.
Our model consisted of ﬁve compartments rep-
resenting the stratum corneum, viable epider-
mis, blood, fat, and other tissues, and contains
fewer parameters than previously published
physiologically based compartmental models of
naphthalene (Quick and Shuler 1999; Willems
et al. 2001). The fat was considered separate
from the other tissues because the time constant
for fat (8.6 hr) was larger than the time con-
stant for other tissues (0.9 hr). However, the
other tissue compartment was included in the
model because the skin compartment consisted
of the skin directly under the exposed area. The
remaining skin was included in the other tissue
compartment. 
Adjustments were made to the fat:blood
and other tissue:blood partition coefﬁcients for
the PBTK model predictions to ﬁt the experi-
mental and occupational exposure data. For
many chemicals, the partition coefﬁcients are
not known. In such cases, quantitative struc-
ture–activity relationship (QSAR) models may
be used to predict the necessary partition coef-
ﬁcients; however, the predictions are limited to
chemicals with physicochemical properties that
lie within the calibration data set (Beliveau
et al. 2003). In our study we calibrated the val-
ues of Pf:b and Po:b, which were predicted by
Willems et al. (2001) using QSAR models,
against human exposure data. We estimated a
Pf:b value of 25.6 for naphthalene, which is
more plausible than 160 given that the Pf:b for
benzene is 55 and 25 for decane. Using the vial
equilibration technique of Gargas et al. (1989),
we also measured a Pb:a value of 10.3 for naph-
thalene, which is more consistent with the Pb:a
for other compounds than is the value of 571
reported by Willems et al. (2001). For exam-
ple, the human Pb:a for benzene, cyclohexane,
JP-10, and p-xylene were 8.19, 1.41, 52.5, and
44.7, respectively (Gargas et al. 1989). 
The PBTK model was used to calculate the
permeability coefﬁcient (Kp) for naphthalene
in humans in vivo. Previously, the Kp had been
calculated using Fick’s law of diffusion. A
Kp value of 5.1 × 10–4 cm/hr was estimated for
rat skin in vitro (McDougal et al. 2000). This
in vitro Kp value was compared with a Kp value
that was estimated by calculating the ﬂux value
for aromatic and aliphatic components of JP-8
in humans from the slope of the linear portion
of the cumulative mass of chemical in blood
per square centimeter versus time curve (Kim
et al. 2006a). We calculated an apparent Kp of
5.3 × 10–5 cm/hr, which is approximately an
order of magnitude lower than that for the rat
Kp. This Kp calculation was revised using a
DTK model and Equation 9. A larger Kp value
was estimated (1.8 × 10–3 cm/hr), which was
more similar to the Kp estimated in vitro by
McDougal et al. (2000). The limitation of
using a data-based compartmental model is
that the parameter values are not constrained
by the actual anatomy and physiology of the
human body and the biochemistry of naphtha-
lene in vivo. We incorporated such constraints
into our PBTK model and revised our calcula-
tion of Kp for naphthalene. We estimated a Kps
value of 6.8 × 10–5 cm/hr and a Kpv value of
3.0 × 10–3 cm/hr. The value of Keff, which is
the overall permeability coefﬁcient for chemi-
cals crossing the skin (McCarley and Bunge
2001), is 6.6 × 10–5 cm/hr.
Keff is approximately 7-fold smaller than
the Kp reported by McDougal et al. (2000). A
7-fold difference was not unexpected because
rat skin used in the McDougal et al. (2000)
study is generally considered more permeable
than human skin. Molecular diffusion is the
dominant mechanism that governs the per-
meation of naphthalene across the skin. For
diffusion, the flux (and Kp) is inversely pro-
portional to the thickness of the diffusion dis-
tance, as stated by Fick’s ﬁrst law of diffusion.
Therefore, doubling the thickness of the skin
will result in halving the Kp. McDougal et al.
(2000) estimated Kp across rat skin of thick-
ness 560 μm. The human skin thickness
ranges from 500 μm to 4,000 μm; therefore,
the human Kp value is expected to be between
6.4 × 10–5 cm/hr and 5.7 × 10–4 cm/hr. Our
estimate of the effective permeability coeffi-
cient for naphthalene lies within this range of
expected values. 
Figure 3. Model simulations and end-exhaled breath concentrations for the U.S. Air Force personnel who were exposed to JP-8 via inhalation and dermal routes.
Breath samples were collected immediately at the end of the work shift and at a central testing site. Shown are the measured and predicted values for three U.S.
Air Force personnel who represented the 10th (A), 50th (B), and 90th (C) percentiles of measured end-exhaled breath concentrations. Simulations are also shown
after adjusting the air concentration of naphthalene during work to better estimate the true inhalation exposure [adjusted (Adj) model].
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Table 3. Input parameters and values for prediction of end-exhaled breath concentrations of naphthalene
in the U.S. Air Force personnel who represented the 10th, 50th, and 90th percentiles based on end-exhaled
breath measurements.
Percentile
Variable 10th 50th 90th
Height (cm) 175 188 168
Body weight (kg) 81 109 73
INHAL1est (µg/m3) 499 322 3,640
INHAL2est (µg/m3) 2.0 2.0 2.0
DERMDOSE (µg/cm2) 3.9 × 10–5 5.5 × 10–4 9.2 × 10–3
Duration of exposure (min) 224 322 260The optimized PBTK model was used to
predict end-exhaled breath measurements col-
lected in the workplace for the U.S. Air Force
personnel exposed to JP-8 by the inhalation
route. The predicted concentration at the end
of their work shift was the same as the meas-
ured values. Further comparisons of predicted
versus measured values revealed considerable
interindividual variability. Sources of hetero-
geneity in a population may include physical
condition, level of activity, disease state, age,
hormonal status, and interactions with other
chemicals and drugs (Clewell and Andersen
1996). Further, we observed considerable
variation in the values of Kps and Kpv, but the
small sample size (10 subjects) limited the
analysis of variability in our study. Further
study of the heterogeneity of parameter values
and the impact on the toxicokinetic proﬁle of
naphthalene in humans is needed.
We also used the optimized PBTK model
to examine dermal and inhalation exposure to
JP-8. Three U.S. Air Force personnel were
selected who represented the 10th, 50th, and
90th percentiles based on their end-exhaled
breath concentrations. The predicted concen-
trations of naphthalene were well above what
was expected in end-exhaled breath. For
example, for the personnel representing the
50th percentile, INHAL1est overpredicted the
end-exhaled breath concentration of naphtha-
lene by 1,540% (i.e., 75.8 μg/m3 vs. 4.6 μg/
m3). The reason for overpredicting breath
concentrations was that these workers wore
personal protective equipment that included
forced supply-air respirators while working in
fuel tanks. Thus, the air concentration that
was measured using the passive monitors was
not the actual air concentration that the Air
Force personnel were exposed to while work-
ing inside the fuel tanks. 
The PBTK model was exercised to obtain a
better estimate of the air concentration that
corresponded to the breath measurements. The
adjusted air concentration was used in our cal-
culation of the relative contribution of dermal
exposure to the end-exhaled breath concentra-
tion of naphthalene. We observed that the
median contribution of dermal exposure to the
end-exhaled breath concentration of naphtha-
lene was relatively small (4%). However, in the
U.S. Air Force personnel who represented the
90th percentile, the relative contribution of der-
mal exposure to the end-exhaled breath con-
centration was 11%. The U.S. Air Force
personnel examined in this study comprised
fuel-cell maintenance workers. Thus, the use of
dermal protective equipment can further
decrease the end-exhaled breath concentration
of naphthalene in the fuel-cell maintenance
workers.
This PBTK model has reduced the uncer-
tainty in modeling JP-8 exposures because
fewer parameters were required to predict the
time-course of naphthalene. However, our
model has identified some data gaps. First,
inhalation exposures should be measured over
shorter time intervals. Sensitivity analysis
demonstrated that end-exhaled breath levels of
naphthalene were most sensitive to the air
concentration of naphthalene during work. In
our study, we used time-weighted average con-
centrations (over approximately 4 hr) that did
not capture exposures to high levels of naph-
thalene from local sources. Therefore, shorter
time-resolved data may be used to better
explain the transient nature of inhalation
exposures to JP-8. Second, occupational and
environmental exposure studies of other com-
ponents of JP-8 are needed to gain a more
complete picture of JP-8 exposures. Currently,
occupational exposure studies have focused on
single chemical components of JP-8. The
results of multichemical exposure assessment
studies may be compared with results from
single-chemical studies and add to our under-
standing of the absorption, distribution,
metabolism, and elimination of complex
chemical mixtures.
The modeling approach used in this study
represents a useful technique for assessing the
contribution of dermal and inhalation expo-
sures to the systemic levels of chemicals. One
of the primary applications of this work could
be to improve the understanding of exposure
processes by quantifying the relationship
between external exposure measurements and
biomarkers of internal dose. For example, a
series of air and dermal exposure measure-
ments may be collected from a sample of
individuals from groups stratiﬁed by ﬁxed fac-
tors such as location relative to the source of
exposure. One could, for example, introduce
an intervention (e.g., respirators) and use the
PBTK model to quantify the efficacy of the
intervention for reducing systemic levels of
the toxicant. This approach would be useful
for protecting the health of individuals. For
example, if the concentration of the exposure
biomarker (i.e., blood and/or breath concen-
tration) is driven primarily by the dermal
route in a given group, there would be little
advantage in additional respiratory protec-
tion. This approach may be used in both
occupational and environmental risk assess-
ment applications. However, additional mod-
eling and experimental studies are required
before generalization of this model to conﬁrm
scenarios/dose metrics beyond the limitations
of the current study.
In conclusion, we used the PBTK model to
quantify the contribution of dermal exposures
Kim et al.
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Table 4. Estimated contribution of dermal exposure to the end-exhaled breath concentrations of naphtha-
lene relative to inhalation exposure.a
Percentile Breath (µg/m3) AUCex (µg × min/m3) INHAL1adj (µg/m3) INHAL1pred (µg/m3) Ratio (%)
10th 1.7 1.7 7.4 0.1 1
50th 4.7 41.7 18.8 0.7 4
90th 29.4 521 103 11.7 11
aThis analysis was based on three U.S. Air Force personnel whose end-exhaled breath concentrations represented the
10th, 50th, and 90th percentiles. The ratio of INHAL1pred to INHAL1adj is a measure of the relative percent contribution of
dermal exposure to the end-exhaled breath concentration. 
Figure 4. Normalized sensitivity coefﬁcients for the end-exhaled breath concentrations. Parameters were
adjusted at the 1% level. 
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to the systemic levels of naphthalene. We
estimated a permeability coefficient that was
7-fold lower than estimates for rat skin made
in vitro. Our approach used a combination of
exposure assessment, biological monitoring,
and toxicokinetic modeling tools to integrate
external exposure and biomarker data into a
single description of the toxicokinetic behavior
of naphthalene. The PBTK model incorpo-
rated exposures from both dermal and inhala-
tion routes and required estimation of fewer
parameters than previously published PBTK
models of naphthalene. This PBTK model,
which included two major exposure routes rel-
evant to occupational and environmental
exposure scenarios, may be used for integrat-
ing animal and human observational studies
into an improved understanding of human
health risks for JP-8. A wide range of perme-
ability coefﬁcient values was noted in the indi-
viduals in this research and further study of
the sources of inter- and intraindividual varia-
tion in these processes appears necessary.
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